Rationalisation of Polypharmacy by the Geriatric Consultation Team Using the RASP List: a Pilot Study
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Iatrogenic Disease
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Number of medication-related recommendations by the geriatric consultation team.
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
Polypharmacy is a common problem in elderly, leading among others to increased adverse drug events. The aim of this pilot study was to evaluate whether a systematic medication evaluation by a geriatric consultation team using the RASP (Rationalisation of drugs on admission by an adjusted STOPP*-list in older patients) list could reduce inappropriate prescribing for elderly admitted patients, admitted to non-geriatric departments.
(* = Screening Tool of Older Persons' potentially inappropriate Prescriptions)
Detailed Description
Polypharmacy and (potentially) inappropriate prescribing is highly prevalent in the older population, associated with increase health care expenditures, morbidity and avoidable adverse events . The aim of this pilot study was to evaluate whether a systematic medication evaluation by a geriatric consultation team (GCT) using the RASP (Rationalisation of drugs on admission by an adjusted STOPP-list in older patients) list could reduce inappropriate prescribing for older admitted patients, admitted to non-geriatric departments. The GCT could offer the ideal format to deliver the intervention to a broad older hospitalised population.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Admitted to a non-geriatric ward
- •75 years or older
- •Dutch speaking
- •Consultation by the GCT
Exclusion Criteria
- •End-of-life
- •No drugs on admission
Outcomes
Primary Outcomes
Number of medication-related recommendations by the geriatric consultation team.
Time Frame: The number was ascertained at time of discharge from the ward, taking into account an average hospital stay of 14 days.
Secondary Outcomes
- Number of drugs at discharge, relative to the drugs on admission.(The number was ascertained at time of discharge from the ward, taking into account an average hospital stay of 14 days.)
- Number of potentially inappropriate drugs at discharge, as identified by the RASP list.(The number was ascertained at time of discharge from the ward, taking into account an average hospital stay of 14 days.)
- Acceptance rate of the GCT interventions by the treating physician.(Up to 72 hours after the GCT had given its recommendations.)